Abstract
ObjectiveIn this study we investigated response rates of bevacizumab in addition to weekly paclitaxel and carboplatin in neoadjuvant setting in cervical cancer stage IB–IIB.MethodsIn this retrospective study we included patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have